Headquartered in New York City, with research centered in Israel, Qrons is an innovative biotechnology company dedicated to developing products to combat neuronal and infectious diseases with a focus on antibiotic resistant bacteria, which is becoming the most prominent and rapidly growing worldwide cause of illness and death. Qrons’ approach is to seek to engage in strategic arrangements with companies universities and, scientists that are developing unique know how and intellectual properties in the fields of, stem cells , antibiotic resistant drug development and tissue engineering, for deployment in the fight against neuronal and infectious diseases